Style | Citing Format |
---|---|
MLA | Azimi A, et al.. "Incidence of Seroconversion and Sero-Reversion in Patients With Multiple Sclerosis (Ms) Who Had Been Treated With Natalizumab: A Systematic Review and Meta-Analysis." Journal of Clinical Neuroscience, vol. 71, no. , 2020, pp. 129-134. |
APA | Azimi A, Hanaei S, Sahraian MA, Mohammadifar M, Ramagopalan SV, Ghajarzadeh M (2020). Incidence of Seroconversion and Sero-Reversion in Patients With Multiple Sclerosis (Ms) Who Had Been Treated With Natalizumab: A Systematic Review and Meta-Analysis. Journal of Clinical Neuroscience, 71(), 129-134. |
Chicago | Azimi A, Hanaei S, Sahraian MA, Mohammadifar M, Ramagopalan SV, Ghajarzadeh M. "Incidence of Seroconversion and Sero-Reversion in Patients With Multiple Sclerosis (Ms) Who Had Been Treated With Natalizumab: A Systematic Review and Meta-Analysis." Journal of Clinical Neuroscience 71, no. (2020): 129-134. |
Harvard | Azimi A et al. (2020) 'Incidence of Seroconversion and Sero-Reversion in Patients With Multiple Sclerosis (Ms) Who Had Been Treated With Natalizumab: A Systematic Review and Meta-Analysis', Journal of Clinical Neuroscience, 71(), pp. 129-134. |
Vancouver | Azimi A, Hanaei S, Sahraian MA, Mohammadifar M, Ramagopalan SV, Ghajarzadeh M. Incidence of Seroconversion and Sero-Reversion in Patients With Multiple Sclerosis (Ms) Who Had Been Treated With Natalizumab: A Systematic Review and Meta-Analysis. Journal of Clinical Neuroscience. 2020;71():129-134. |
BibTex | @article{ author = {Azimi A and Hanaei S and Sahraian MA and Mohammadifar M and Ramagopalan SV and Ghajarzadeh M}, title = {Incidence of Seroconversion and Sero-Reversion in Patients With Multiple Sclerosis (Ms) Who Had Been Treated With Natalizumab: A Systematic Review and Meta-Analysis}, journal = {Journal of Clinical Neuroscience}, volume = {71}, number = {}, pages = {129-134}, year = {2020} } |
RIS | TY - JOUR AU - Azimi A AU - Hanaei S AU - Sahraian MA AU - Mohammadifar M AU - Ramagopalan SV AU - Ghajarzadeh M TI - Incidence of Seroconversion and Sero-Reversion in Patients With Multiple Sclerosis (Ms) Who Had Been Treated With Natalizumab: A Systematic Review and Meta-Analysis JO - Journal of Clinical Neuroscience VL - 71 IS - SP - 129 EP - 134 PY - 2020 ER - |